含1,2,4-三唑席夫碱的新型喹唑啉-2,4-二酮类衍生物的合成及其抗细菌活性研究

利用活性亚结构拼接原理,设计合成了18个含1,2,4-三唑席夫碱结构单元的喹唑啉-2,4-二酮类化合物7a~7r,通过~1H NMR、~(13)C NMR、MS、IR和元素分析对它们的结构进行了表征.初步抗菌测试结果表明,所有目标化合物在200μg/m L浓度下对水稻白叶枯病菌都表现出优良的抑制活性(≥93%),明显优于对照药剂噻菌铜和叶枯唑;其中化合物7a、7c~7g和7j~7l在100μg/m L浓度下对水稻白叶枯病菌的抑制率仍达100%.此外,所有目标化合物对柑橘溃疡病菌都表现出一定的抑制作用,但对烟草青枯病菌几乎无抑制活性.     

2-(1H-苯并咪唑-2-基)-5-取代-1,3,4-噁二唑化合物的合成及抑菌活性

以苯并咪唑-2-甲酸、水合肼、取代苯基异硫氰酸酯和取代苯甲酸等为原料,经多步反应合成了16种2-(苯并咪唑-2-基)-5-取代苯基-1,3,4-噁二唑和2-(苯并咪唑-2-基)-5-取代苯胺基-1,3,4-噁二唑新化合物,并考察了微波辐射对反应的影响.产物结构利用IR,1H NMR,13C NMR和元素分析确证.用生长速率法测试了目标化合物对番茄灰霉病菌和小麦菌核病菌的离体抑制活性,结果表明3种化合物对番茄灰霉病菌有很高的抑制活性,其EC50分别为2.55,6.34和5.12μg/mL,活性高于对照药剂多菌灵(EC50=7.40μg/mL).     

2,3-二芳基-1,3-苯并噁嗪的合成及杀菌活性

在三甲基氯硅烷(TMSCl)的催化作用下,取代苯甲醛与邻(芳胺甲基)苯酚经N杂缩醛化反应生成了一系列2,3-二芳基-1,3-苯并噁嗪类化合物。 目标化合物的结构用IR、¹H NMR、¹³C NMR和元素分析等技术手段进行了表征。 对所合成的化合物进行了初步杀菌活性测试,部分表现出良好的杀菌活性,化合物6e对菌核病菌的抑制活性为79.0%,化合物6a和6d均为74.8%,化合物6e对灰霉病菌的抑制活性为77.9%。     

含4(3H)-喹唑啉酮结构的取代1,3,4-噁二唑(噻二唑)化合物的合成及抗菌活性研究

以2-胺基苯甲酸为原料,通过环化、缩合、肼解、环化、硫醚化和氧化等步骤,合成了10个含喹唑啉酮取代1,3,4-噁二唑(噻二唑)化合物。通过1H NMR、13C NMR、MS 和元素分析进行确证其结构。初步抑菌活性测试表明,化合物浓度在50 μg/mL时,对葡萄座腔菌(Botryosphaeria dothidea)、拟茎点霉菌(Phomopsis sp.)和灰霉菌(B. cinerea)具有中等抑制活性。另外,目标化合物对猕猴桃溃疡病(Pseudomonas syringae pv. actinidia)均具有一定的抑制活性,其中化合物6a和6b对猕猴桃溃疡病的EC50值为11.7 μg/mL和20.5 μg/mL,优于对照药剂叶枯唑(24.5 μg/mL)。这类化合物具有较好抗菌的生物活性,在此基础上进行结构优化,有望发现较高活性化合物。     

4H-3,1-苯并噁嗪-4-酮衍生物的合成及α-葡萄糖苷酶抑制活性研究

为了探索高效低毒的新型α-葡萄糖苷酶抑制剂,设计并合成了一系列4H-3,1-苯并噁嗪-4-酮衍生物,其结构经过¹H NMR、¹³C NMR和HRMS鉴定。体外α-葡萄糖苷酶抑制活性测定结果表明,化合物3a、4a、5a和4j的IC₅₀值分别为68.3、76.1、99.3和51.9μmol/L,明显优于阳性对照阿卡波糖(IC₅₀=421.7μmol/L)。此外,分子对接研究结果表明化合物3a和4j与α-葡萄糖苷酶存在较强的亲和力。     

2-(1H-吲哚-3-基)-5-砜基噁二唑衍生物的合成及其生物活性研究

以吲哚-3-甲酸甲酯为原料,通过肼解、环合生成5-(1H-吲哚3-基)-1,3,4-噁二唑-2-硫醇,再对其进行亲核取代和氧化反应得到目标化合物,并通过¹H NMR、¹³C NMR和HRMS确认其结构。采用噻唑蓝(MTT)法测试了目标化合物对几种癌细胞的体外抑制活性,同时采用比浊法对几种植物病原菌进行了体外抑菌活性测试。结果表明,化合物对于A549(人肺癌细胞)、PC-3(人前列腺癌细胞)、K562(人慢性髓原白血病细胞)和HepG2(人肝癌细胞)四种癌细胞有一定的抑制活性;对水稻白叶枯病菌(Xanthomonas oryzae pv.oryzae,Xoo)、柑橘溃疡病菌(Xanthomonas axonopodis pv.citri,Xac)以及猕猴桃溃疡病菌(Pseudomonas syringae pv.actinidiae,Psa)三种植物病菌同样具有一定的抑菌活性。其中,化合物4f对Xoo的体外抑制率可达87.09%(100μg/mL)和54.02%(50μg/mL)。本文结果可为具有砜结构的吲哚衍生物的合成及应用研究提供参考。     

含1,3,4-噻二唑杂环的甲氧基丙烯酸酯类化合物的合成与杀菌活性研究

以多种取代苯甲酸为原料,通过酰化、醇解、肼解、亲核加成、脱水、亲核取代等多步反应,合成了16个未见文献报道的含1,3,4-噻二唑杂环的甲氧基丙烯酸酯类化合物,其结构均通过1H NMR,IR,MS,HRMS等予以表征确认,并对所有化合物进行了离体杀菌活性测试.结果表明:对水稻立枯和棉花枯萎病菌的防效好于番茄晚疫病菌,对西瓜炭疽病菌防效显著,其中化合物5a~5c,5g,6a~6c的抑制率均高于嘧菌酯,5g在100μg/mL下抑制率为77.5%.     

含磺酰胺结构的1,3,4-噁二唑砜类化合物的设计、合成及抗菌活性研究

为了寻找新型抗菌剂,采用活性亚结构拼接,设计合成了23个含磺酰胺结构的1,3,4-噁二唑砜类化合物,并对其抗菌活性进行了测试.在100μg/m L浓度下,大多数化合物对水稻细菌性条斑病菌(Xanthomonas oryzae pv.oryzicola)和水稻白叶枯病菌(Xanthomonas oryzae pv.oryzae)表现出优异的离体抗菌活性.除N-((5-(丙基磺酰基)-1,3,4-噁二唑-2-基)甲基)-4-(三氟甲基)苯磺酰胺(18)外,所有化合物对水稻细菌性条斑病菌的半数有效浓度(EC₅₀)值为1.3～22.5μg/mL所有化合物对水稻白叶枯病菌的EC₅₀为1.1～32.7μg/m L,均优于对照药剂叶枯唑(84.1和71.4μg/mL)和噻菌酮(122.1和84.0μg/m L).此外,4-氟-N-((5-(甲基磺酰基)-1,3,4-噁二唑-2-基)甲基)苯磺酰胺(4)可以通过抑制胞外多糖(EPS)的产生、生物膜的形成以及改变细胞膜的通透性和细胞表面形态,从而抑制水稻细菌性条斑病菌和水稻白叶枯病菌的正常生长.     

含1,2,4-三唑席夫碱的新型喹唑啉类化合物的合成及其抗菌活性研究

以3-甲基-4-氨基-1,2,4-三唑-5-硫酮、芳醛和4-氯喹唑啉为原料,经席夫碱和硫醚化反应合成了14个新型的含1,2,4-三唑席夫碱单元的喹唑啉类化合物6a～6n,通过IR,1H NMR,MS及元素分析对所合成的目标化合物进行了结构表征.初步生物活性测试结果表明,部分化合物表现出一定的抗菌活性.在50μg/mL浓度下,化合物6g对辣椒枯萎菌、苹果腐烂菌及马铃薯晚疫菌的抑制率分别为71%,72%和58%.     

含苯并三嗪酮的1,4-戊二烯-3-酮衍生物的合成及抑菌活性

为了得到生物活性较好的姜黄素衍生物,通过1-苯基-5-取代基-1,4-戊二烯-3-酮和3-氯甲基苯并三嗪酮反应,合成了14个含苯并三嗪酮的1,4-戊二烯-3-酮衍生物;采用核磁共振波谱(NMR)和高分辨质谱(HRMS)对化合物的结构进行了表征.初步的生物活性测试结果表明,部分化合物显示出较好的抑菌活性,在100μg/mL剂量下,化合物6b,6j和6l对柑橘溃疡病菌(Xac)的抑制率分别为68.8%,71.0%和100%;化合物6a,6d,6h和6i对烟草青枯病菌(R.solanacearum)的抑制率分别为51.8%,53.0%,50.7%和76.9%.此外,化合物6l和6i对柑橘溃疡病菌和烟草青枯病菌的半最大效应浓度(EC50)值分别为27.44和48.77μg/mL,优于对照药剂噻菌铜(51.35和87.26μg/mL),有望成为柑橘溃疡病菌和烟草青枯病菌的抑制剂.     

Synthesis,in vitro Antimicrobial,and Cytotoxic Activities of New 1,3,4‐Oxadiazin‐5(6H)‐one Derivatives from Dehydroabietic Acid

A series of new 1,3,4‐oxadiazin‐5(6H)‐one derivatives ( 6a–n ) of dehydroabietic acid were designed and synthesized as potential antimicrobial and antitumor agents. Their structures were characterized by IR, ¹H NMR, ¹³C NMR, MS, and elemental analyses. All the title compounds were evaluated for their antimicrobial activity against four bacterial and three fungal strains using the serial dilution method. Among them, compound 6e showed the highest antibacterial activity against Bacillus subtilis with a minimum inhibitory concentration (MIC) value of 1.9 μg/mL. In addition, the in vitro cytotoxic activities of the title compounds were also assayed against three human carcinoma cell lines (MCF‐7, SMMC‐7721, and HeLa) through the MTT colorimetric method. As a result, compounds 6b , 6g , 6k, and 6m exhibited significant inhibition against at least one cell line with IC₅₀ values below 10 μM. Compound 6m was especially found to be the most potent derivative with IC₅₀ values of 2.26 ± 0.23, 0.97 ± 0.11, and 1.89 ± 0.31 μM against MCF‐7, SMMC‐7721, and HeLa cells, respectively, comparable to positive control etoposide.     

含1,3,4-噁二唑结构的新型吡唑肟醚类衍生物的合成及杀虫活性

为了寻找具有较好生物活性的吡唑肟醚类衍生物,基于唑螨酯的结构,在吡唑环的4-位引入1,3,4-噁二唑结构,设计合成了15个结构新颖的吡唑肟醚类化合物,它们的结构通过1H NMR、13C NMR、元素分析等手段得到表征.生测研究表明,部分目标化合物在500和100μg/mL浓度下对粘虫(Oriental armyworm)或蚜虫(Aphis medicaginis)都有较好的杀虫效果,其中10a, 10e, 10f和10j在100μg/mL时对粘虫有100%的杀死率, 10g, 10j和10l在100μg/mL时对蚜虫有100%的杀虫活性.另外, 10l在500μg/mL浓度下对朱砂叶螨(Tetranychus cinnabarinus)也具有100%的杀灭效果.     

Synthesis,in vitro antibacterial and antifungal evaluation of novel 1,3,4-oxadiazole thioether derivatives bearing the 6-fluoroquinazolinylpiperidinyl moiety

A series of structurally novel 1,3,4-oxadiazole thioether derivatives(6a-6z) containing a 6-fluoroquinazolinylpiperidinyl moiety were designed and synthesized using pharmacophore hybrid approach,and their structures were fully characterized by ^1H NMR,¹³C NMR and HRMS spectra.Among them,the structure of compound 6 d was further corroborated via single-crystal X-ray diffraction analysis.In vitro antibacterial bioassays showed that compounds 6 a,6 g,6 u and 6 v possessed EC₅₀ values of 30.4,30.6,27.5 and 26.0 μg/mL against phytopathogenic bacterium Xanthomonas oryzae pv.oryzae,respectively,which were significantly superior to that of commercially-available bactericide Bismerthiazol(85.1 μg/mL).Moreover,in vitro antifungal bioassays indicated that seven compounds demonstrated broad-spectrum fungicidal acitivties against six types of phytopathogenic fungi at 50 μg/mL.The present work showed the potential of 1,3,4-oxadiazole thioether derivatives carrying a 6-fluoroquinazolinylpiperidinyl moiety as effective antimicrobial agents for crop protection,deserving further investigations in the future.     

新型六氢吡啶-2,3-并吲哚化合物的合成及其抗肿瘤活性

以3-取代氧化吲哚与丙烯酸酯为原料,经Michael加成反应制得中间体--3-丙酸酯取代氧化吲哚（3a~3d）; 3a~3d与甲胺发生酰胺化反应制得3 丙酰胺取代氧化吲哚（4a~4d）; 4a~4d用氢化铝锂还原-环化,合成了4个六氢吡啶-2,3-并吲哚化合物(5a~5d）; 5a和5b用氢化铝锂还原合成了2个六氢吡啶-2,3-并吲哚化合物（6a和6b）, 5a～5d, 6a和6b均为新化合物,总产率42%～61%,其结构经¹H NMR, ¹³C NMR和HR-ESI-MS表征。采用MTT法研究了5a～5d, 6a和6b对人肺癌细胞（A549）,人前列腺（PC-3）和人白血病细胞（K562）的体外抗肿瘤活性。结果表明：5b对A549, PC 3和K562的抑制活性均较好,其IC₅₀分别为27.2μmol·L^-1, 37.5 μmol·L^-1和21.7 μmol·L^-1。     

新型含肟醚Strobilurins衍生物的合成及杀菌活性研究

Strobilurins类化合物具有优异的杀菌活性, 设计并合成了12个未见文献报道的含肟醚Strobilurins类衍生物, 其化学结构经1H NMR, IR, HPLC/MS和元素分析表征. 初步生物活性测定结果表明, 该类化合物具有良好的杀菌活性, 如6b～6d和6h在500 μg/mL浓度下对小麦白粉病菌的防效达90%以上, 同时, 6c和6d对稻瘟病菌的抑制率也达90%以上, 其中, 化合物6c在25 μg/mL的浓度下, 对小麦白粉病菌的防效仍达72%.     

新型桃金娘烯醛基双酰胺-噻二唑化合物的合成及其抗真菌活性

以α-蒎烯为起始原料,经氧化制得桃金娘烯酸（3）;脂肪族二酸在POCl₃作用下与氨基硫脲经脱水环合制得脂肪族双噻二唑（4a~4h）; 4a~4h分别与3经脱水反应合成了8个新型的桃金娘烯醛基双酰胺噻二唑化合物（5a~5h）,其结构经¹H NMR, ¹³C NMR, IR和ESI-MS表征。抗真菌活性测试结果表明,在用药量为50 μg·mL^-1时,5a~5h对黄瓜枯萎病菌、花生褐斑病菌、苹果轮纹病菌、番茄早疫病菌和小麦赤霉病菌均有一定的抑制作用,其中桃金娘烯醛-辛二酸基双酰胺-噻二唑(5f)对苹果轮纹病菌的抑制率为60.3%,桃金娘烯醛-丁二酸基双酰胺-噻二唑(5b)和桃金娘烯醛-癸二酸基双酰胺-噻二唑(5h)对小麦赤霉病菌的抑制率分别为52.8%和54.4%。     

Phenolic glucosides and chromane analogs from the insect fungus Conoideocrella krungchingensis BCC53666

Six new compounds, named conoideoglucosides A − C and conoideochromanes A − C, together with eight known compounds, including eutypinic acid, 2,2-dimethyl-2H-1-chromene-6-carboxylic acid, (−)-luteoskyrin, (−)-4a-oxyluteoskyrin, chrysophanol, islandicin, catenarin, and (22E)-5α,8α-epidioxyergosta-6,22-dien-3β-ol were isolated from the insect fungus Conoideocrella krungchingensis BCC53666. (−)-Luteoskyrin exhibited a broad range of antimicrobial activity such as antimalarial (IC₅₀ 0.51 μg/mL), antitubercular (MIC 6.25 μg/mL), antibacterial (both Gram positive; MIC 0.39–1.56 μg/mL and Gram negative; MIC 3.13–12.50 μg/mL), and antifungal (against various plant pathogens; MIC 3.13–50.00 μg/mL) activities, while (−)-4a-oxyluteoskyrin and catenarin showed weaker antibacterial activity. Moreover, eutypinic acid, (−)-luteoskyrin, (−)-4a-oxyluteoskyrin, and catenarin showed cytotoxicity against NCI-H187 cells with IC₅₀ in a range of 0.16–17.99 μg/mL, while eutypinic acid and catenarin had no cytotoxicity against non-cancerous (Vero) cells at maximum tested concentration (50 μg/mL). The complete NMR spectral data and biological activity of the known (−)-4a-oxyluteoskyrin was also reported for the first time.     

新型吡唑酰腙类化合物的合成及其生物活性

以取代肼和取代乙酰乙酸乙酯为起始原料,依次经闭环、氯酰化、氧化、酯化及取代反应制得1,3-取代-5-氯-4-吡唑甲酰肼（7a, 7d, 7g和7j); 7分别与取代呋喃或噻吩甲醛经加成反应合成了12个新型的吡唑酰腙类化合物(9a~9l),其结构经¹H NMR, ¹³C NMR, IR和元素分析表征。初步的生物活性测试结果表明：在500 μg·mL^-1浓度下,部分化合物对烟草花叶病毒(TMV)具有一定的抑制活性,其中1-苯基-3-三氟甲基-5-氯-4-(2-噻吩)-腙基羰基吡唑(9k)的治疗活性、保护活性和钝化活性分别为63.6%, 85.7%和93.1%,与对照药宁南霉素(65.9%, 86.4%和97.8%)相当;在50 μg·mL^-1浓度下,部分化合物表现出一定的抑菌活性,其中1,3-二甲基-5-氯-4-(2-噻吩)-腙基羰基吡唑(9b)与1-甲基3-三氟甲基-5-氯-4-(2-噻吩)-腙基羰基吡唑(9e)对小麦赤霉病菌(Gibberella zeae)的抑制率分别为42.5%和46.8%。     

氮杂香豆雌酚衍生物的合成及其抗肿瘤活性

以间苯二甲醚为原料, 经碘代、偶联、胺解、分子内环化及脱甲醚环化共5步反应,合成9个氮杂香豆雌酚衍生物（6a~6i）, 其结构经¹H NMR, ¹³C NMR 和APCI-MS表征。采用MTT法研究了6对Hela、 SKOV3、 BEL-7404、 HepG2及A-549等癌细胞的体外生长抑制活性。结果表明：6h对SKOV3细胞的生长抑制活性最高,其IC₅₀值为81.58 μmol·L^-1。     

Indeno[1,2-b]pyridin-5-one derivatives containing azo groups and their hydrazonal precursors: Synthesis,antimicrobial profile,DNA gyrase binding affinity,and molecular docking

The prevalence of germs that are resistant to many antibiotics is rising rapidly the world over. There is a large group of researchers actively looking for better medicines. Here, we designed two series of hydrazonal and indeno[1,2-b]pyridin-5-one bearing hydrazone and azo-groups to test their antimicrobial activity. Molecular structures of all derivatives were assured based on their spectral data and elemental analyses. Results of the antimicrobial activity of the tested hydrazone and azo compounds showed promising potential for several derivatives. The minimum inhibitory concentrations (MICs) of hydrazones 4a - h and 6a - g displayed good antibacterial reactivities with a range of 3.91–250 μg/mL and moderate antifungal activity with a range of 15.6–500 μg/mL. The most promising hydrazone 4f and azo- 6a compounds demonstrated MIC values against Streptococcus faecalis and Escherichia coli equal to 3.91 and 7.81 μg/mL, respectively. Moreover, azo compound 6a showed MIC value equal to 3.91 μg/mL against Enterobacter cloacae species. Additionally, derivative 4f exhibited a significant inhibitory profile against the E. coli gyrase A enzyme (IC₅₀ = 5.53 μg/mL). On the other hand, compound 6a (IC₅₀ 14.05 μg/mL) exhibited the lowest DNA gyrase inhibitory activity as compared to compounds 4f and reference standard drug novobiocin, IC₅₀ 5.53 and 1.88 μg/mL, respectively. Pharmacokinetic and pharmacodynamic profiles and molecular docking studies for the two most promising molecules 4f and 6a were computed and revealed that both compounds have good ADME profiles and high binding affinity to DNA gyrase binding site.